Sexual Health
Is PT-141 nasal spray FDA-approved?
No. PT-141 nasal spray is a compounded prescription. Here's what FDA approved for Vyleesi, what nasal research exists and what to ask before you start.
No. PT-141 nasal spray is not FDA-approved. It's a compounded prescription, prepared by a licensed pharmacy for an individual prescription. The FDA-approved bremelanotide product is Vyleesi, an injection FDA approved in 2019 for a specific group of premenopausal women.
That's the short answer. The more useful one is what it means for you: what FDA actually approved, what has and hasn't been studied, and what to ask about the spray you'd actually receive.
What did FDA actually approve?
FDA approval belongs to a specific finished product: its ingredient, dose, route, device and labeled use, reviewed together. For bremelanotide, that product is Vyleesi, a 1.75 mg single-dose autoinjector given under the skin.
Approval doesn't attach to an ingredient name. A nasal spray containing bremelanotide is a different product, so Vyleesi's approval doesn't cover it, however it's labeled and whoever prescribes it.
| Question | PT-141 nasal spray | Vyleesi |
|---|---|---|
| FDA-approved? | No, it's compounded | Yes, for its labeled use |
| How it's used | Sprayed into the nose | Injected under the skin with an autoinjector |
| Who it's labeled for | No FDA-approved label; a provider decides based on your history | Premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) |
| Where directions come from | Your prescription label and pharmacist | Vyleesi's prescribing information |
The practical rule: ask about the exact product, not just the active ingredient.
What does compounded mean for you?
A compounded medicine is prepared by a pharmacy for a prescription rather than manufactured under an FDA approval. That doesn't make it fake or inferior. FDA recognizes that compounding can serve a real medical need. It also means FDA hasn't reviewed the product's safety, effectiveness or quality before it's dispensed, so the pharmacy's standards and the instructions you receive carry more weight.
A compounded spray is not a generic version of Vyleesi, either. Generics are FDA-approved copies of a brand; compounded medicines aren't approved at all. FDA's position is that compounded drugs belong with patients whose needs aren't met by an approved drug, so it's fair to ask your provider why the spray fits you.
What is Vyleesi actually approved for?
The Vyleesi prescribing information available through DailyMed describes an injectable bremelanotide product approved for certain premenopausal women with acquired, generalized hypoactive sexual desire disorder, or HSDD.
In plain words, the label describes low sexual desire that developed after a period without that problem, occurs across situations rather than only with one partner or circumstance, and causes marked distress or interpersonal difficulty. The labeled condition is not due to another medical or psychiatric condition, relationship problems, or the effects of a medication or drug substance.
The label also states that Vyleesi is not indicated to treat HSDD in men or postmenopausal women, and is not indicated to enhance sexual performance. These limitations describe the approved product; they are not a diagnosis or a recommendation for any reader.
This is why the statement “bremelanotide is FDA-approved” is incomplete when attached to a nasal spray. It leaves out the product, route and approved patient population that give the statement its meaning.
In two large randomized trials, women in that group who used the injection reported more improvement in desire, and less distress about low desire, than women on placebo. The trials did not show a significant increase in the number of satisfying sexual events. Those results belong to the injection in that population. Our guide to how compounded PT-141 and Vyleesi compare covers the studies in more detail.
Has the nasal spray been studied?
The large trials and FDA review were done with the injection. So when you see a claim about how fast a PT-141 spray works, how long it lasts or how well it works, ask which product it came from. Injection results don't automatically carry over to a compounded spray. Don't convert injection directions into nasal-spray directions.
Does approval status change the safety questions?
No. The same health questions apply either way. MintRx's safety information for the spray says not to use it if you are pregnant or breastfeeding, are 18 or younger, or have heart disease or uncontrolled high blood pressure. Common side effects include nausea, flushing and headache.
Our guide to who should talk with a provider before using PT-141 nasal spray covers what to bring up and when to get help. Seek emergency care for trouble breathing or swelling of the face, tongue or throat.
What to ask about the spray you'd actually receive
Because a compounded spray has no FDA-approved label, your prescription label and the pharmacy's insert are your directions. Ask:
- What concentration is it? MintRx's spray is 5 mg/mL. That describes strength, not how many sprays to use. Follow your label.
- How do I prime the pump? Prime it before the first dose and again if it has sat unused, because an unprimed pump can deliver less than a full dose.
- How do I store it? It ships cold and stays in the refrigerator. The pharmacy assigns a 35-day beyond-use date; the exact date is on your label.
- Who do I call with questions? A MintRx pharmacist can walk through the label, the pump and side effects before and after it arrives.
For current pricing and what's included, see the PT-141 nasal spray page.
What happens when you explore treatment through MintRx?
A licensed provider reviews your health information and decides whether a prescription is appropriate. If it is, the pharmacy ships the spray cold, and a MintRx pharmacist stays available for questions afterward. Here's what happens after you start treatment online.
FAQ
Is PT-141 nasal spray the same as Vyleesi?
No. Vyleesi is an FDA-approved injectable bremelanotide product with a specific indication. PT-141 nasal spray is a different formulation.
Does a prescription mean PT-141 nasal spray is FDA-approved?
No. A prescription and FDA approval are separate things.
Can I use injection instructions for a nasal spray?
No. Follow the instructions for your own prescription and ask the dispensing pharmacist if anything is unclear. Do not convert doses or switch formulations yourself.
Is compounded PT-141 a generic version of Vyleesi?
No. A generic is an FDA-approved copy of a brand-name drug. Compounded medicines, including PT-141 nasal spray, are not FDA-approved.
One last thing
Before deciding, ask: “What evidence supports this exact formulation for my situation, and what are its limits?” That question is more useful than asking whether an ingredient has ever appeared in an approved medicine.
For a calm next step, talk to a MintRx pharmacist about the pharmacy side of care, including what to clarify with your licensed provider.
Related guides
- Is compounded PT-141 injection the same as Vyleesi?
- Who should discuss PT-141 nasal spray risks with a provider?
- PT-141 injection
- Sexual health treatments at MintRx
Written and reviewed by Nathan Parker, PharmD.
Sources
- FDA approval letter for Vyleesi (bremelanotide) subcutaneous injection, NDA 210557.
- Vyleesi prescribing information, DailyMed. Covers the approved injection, not the compounded spray.
- Kingsberg SA, et al. "Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials." Obstetrics & Gynecology, 2019.
- FDA, "Compounding and the FDA: Questions and Answers."
- FDA, "Understanding the Risks of Compounded Drugs."
Compounded medicine disclosure
PT-141 nasal spray is a compounded medicine. Compounded medicines are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before they are sold.
